1,307 results on '"Jabado, Nada"'
Search Results
152. SMARCA4 vulnerability in H3K27M midline glioma: A silver bullet for a lethal disease
153. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
154. An inherited immunoglobulin class-switch recombination deficiency associated with a defect in the INO80 chromatin remodeling complex
155. Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data
156. K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomas
157. Additional file 1 of Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data
158. Additional file 9 of Detection and genomic analysis of BRAF fusions in Juvenile Pilocytic Astrocytoma through the combination and integration of multi-omic data
159. Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature
160. Correction to: Efficacy of Dabrafenib for three children with brainstem BRAFV600E positive ganglioglioma
161. Germline PDGFRB p.R987W pathogenic variant in two children with brain tumors
162. TMET-09. LOSS OF MAT2A COMPROMISES METHIONINE METABOLISM AND REPRESENTS A VULNERABILITY IN H3K27M MUTANT GLIOMAS
163. EPCO-38. TYPE B ULTRA LONG-RANGE INTERACTIONS IN PFAS (TULIPS) ARE RECURRENT EPIGENOMIC FEATURES OF PFA EPENDYMOMA
164. CTNI-68. FIREFLY-1 (PNOC026): PHASE 2 STUDY OF PAN-RAF INHIBITOR TOVORAFENIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RAF-ALTERED RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA OR ADVANCED SOLID TUMORS
165. CTNI-31. COG ACNS1721: PHASE 2 STUDY OF VELIPARIB AND LOCAL IRRADIATION, FOLLOWED BY MAINTENANCE VELIPARIB AND TEMOZOLOMIDE, IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA WITHOUT H3 K27M OR BRAF MUTATIONS
166. CTNI-04. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS
167. Failure of human rhombic lip differentiation underlies medulloblastoma formation
168. Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations
169. Brainstem Tumors
170. TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw
171. Brainstem angiocentric gliomas with MYB–QKI rearrangements
172. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors
173. Murine diet/tissue and human brain tumorigenesis alter Mthfr/MTHFR 5′-end methylation
174. Extent of Tumor Resection and Survival in Pediatric Patients With High-Grade Gliomas
175. FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional Circuits
176. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
177. Abstract 5730: FOXR2 is an oncogenic driver across adult and pediatric cancers
178. LGG-58. Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology
179. DIPG-17. CD155 regulates cell growth and immune evasion in diffuse intrinsic pontine glioma
180. HGG-06. Phase 2 Study of Veliparib and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma without H3 K27M or BRAF Mutations: A Report from the Children's Oncology Group ACNS1721 Study
181. HGG-60. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma
182. HGG-36. Elucidating the role of long non-coding RNAs in pediatric high grade gliomas
183. DIPG-19. FOXR2 is an oncogenic driver across pediatric and adult cancers
184. FIREFLY-1 (PNOC 026): A phase 2 study to evaluate the safety and efficacy of tovorafenib (DAY101) in pediatric patients with RAF-altered recurrent or progressive low-grade glioma or advanced solid tumors.
185. DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)
186. NFB-08. TRAM-01: A Phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
187. LGG-26. Predicting MAPK inhibitor sensitivity in pediatric low-grade gliomas with novel gene expression-derived signatures
188. HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.
189. DIPG-37. Exploring the role of the epigenetic factor H2A.Z acetylation in DIPG
190. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
191. Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage
192. De novo TRPV4 Leu619Pro variant causes a new channelopathy characterised by giant cell lesions of the jaws and skull, skeletal abnormalities and polyneuropathy
193. Longitudinal mutational analysis of a cerebellar pilocytic astrocytoma recurring as a ganglioglioma
194. Using comprehensive genomic and functional analyses for resolving genotype–phenotype mismatches in children with suspected CMMRD in Lebanon: an IRRDC study.
195. Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
196. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
197. The role of resection alone in select children with intracranial ependymoma: the Canadian Pediatric Brain Tumour Consortium experience
198. Author Correction: Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome
199. Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4)
200. Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.